Waters Corp stock steadies as shareholders approve Reverse Morris Trust deal
Published on 09/14/2026 at 13:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Waters Corp stock (ISIN US9418481035) is trading against the backdrop of a key corporate milestone after shareholders approved issuing new common shares to complete a Reverse Morris Trust transaction with Becton, Dickinson and Company on September 13, 2026, while the latest quarterly figures showed year-over-year growth in revenue and earnings for the analytical instruments specialist.
Shareholders back Reverse Morris Trust structure
According to StockTitan on September 13, 2026, Waters Corporation reported in a Form 8-K filing that its shareholders have approved the issuance of Waters common stock needed to complete its previously announced Reverse Morris Trust transaction with Becton, Dickinson and Company and Augusta SpinCo Corporation.
The Reverse Morris Trust structure typically allows a company to combine a business carve-out with a tax-efficient merger, and the approval of new Waters shares is a key procedural step toward closing the deal, which is designed to position the combined operations with a stronger balance of scale and specialization in diagnostics-related analytical workflows.
Recent fundamentals underline earnings power
For investors, the latest reported quarterly figures remain central in assessing Waters Corp stock alongside the transaction narrative. In its most recent quarter ended within the last nine months and presented as the latest available interim report, Waters Corporation generated revenue of approximately USD 1.77 billion, up about 6.5 percent from around USD 1.66 billion in the comparable period a year earlier, according to data summarized in a recent research overview on MarketBeat.
Operating performance improved along with the top line: net income for the same quarter reached roughly USD 430 million compared with about USD 400 million a year earlier, implying earnings growth of 7.5 percent year-on-year as Waters continued to benefit from demand for high and ultra-performance liquid chromatography and mass spectrometry systems used in pharmaceuticals and life sciences.
Over that reported period, Waters also maintained a robust operating margin in the low- to mid-20s percent range, illustrating that the company managed to convert revenue growth into profit despite ongoing investment in product development and service support for its analytical workflow solutions.
Analyst lens and sector positioning
As the Reverse Morris Trust deal progresses, Waters Corp stock sits in a broader group of water-related and analytical instrumentation names that have drawn attention in recent days. A sector roundup from MarketBeat on September 13, 2026 highlighted Waters among five water-linked stocks with the highest recent dollar trading volume, emphasizing its role as a provider of analytical workflow solutions to customers in Asia, the Americas and Europe.
In that same overview, Waters was described as operating through two segments, Waters and TA, designing, manufacturing, selling and servicing high and ultra-performance liquid chromatography systems and mass spectrometry technology, alongside consumables and post-warranty service plans, which together underpin a recurring revenue base and help frame analyst models for future cash flows.
From an investor perspective, the combination of a still-growing revenue base, solid margins and the structural change implied by the Reverse Morris Trust transaction with Becton, Dickinson creates a mixed risk-reward profile: while the deal could unlock synergies and strategic focus, it also adds execution risk and potential integration challenges that analysts will watch closely over the coming quarters.
Insider activity adds nuance
In addition to the shareholder vote, insiders have been active in Waters shares. A Form 4 filing cited by StockTitan on September 13, 2026 reported that a Waters executive sold 3,626 common shares at a price of USD 397.94 per share in an open-market or private transaction.
While a single insider sale does not necessarily signal a change in company fundamentals, such transactions can influence short-term sentiment, especially when they coincide with major corporate events like the approval of share issuance for a merger-related structure.
Stock trades calmly on Nasdaq
Against this backdrop, Waters Corp stock ended the last completed U.S. trading session on the Nasdaq on September 11, 2026 at a closing price that sat between the day’s intraday high and low, reflecting a relatively muted move in percent terms compared with the prior session per Nasdaq data cited in a recent market wrap.
Per a corporate-news overview on September 14, 2026, Waters Corp (NYSE: WAT) underperformed the S&P 500 index over the week through September 11, 2026, with the stock’s cumulative percentage gain lagging the benchmark, underscoring a cautious investor stance even as broader U.S. equities recorded a notable advance.
Key data on Waters Corp stock
- Company: Waters Corporation
- ISIN: US9418481035
- Ticker: WAT
- Trading venue: Nasdaq
- Sector / Industry: Health care equipment and life sciences tools
- Index membership: S&P 500
